About SciBase
SciBase is a publicly listed company based in Stockholm (Sweden) founded in 1998 by Stig Ollmar. Point-of-care device for malignant melanoma detection is provided. It operates on a HealthTech and Direct-to-Consumer (D2C) model. SciBase has raised $22.3 million across 3 funding rounds from investors including SEB, CapMan and Van Herk Groep. The company has 32 employees. Its chief executive, as recorded, is Emanuel von Kienlin. SciBase offers products and services including Nevisense and Skin Barrier Assessment. Its focus areas include Medical Devices and Diagnostic Equipment. Its legal entity is SciBase AB.
Company details
SciBase is focused on the development and commercialization of Nevisense, a point-of-care platform integrating AI and advanced EIS technology. The company operates in the healthcare sector, specifically targeting early detection and prevention of skin cancer and skin disorders. Solutions provided by SciBase empower healthcare professionals to improve diagnostic accuracy, facilitate disease monitoring, and enable early intervention. The platform is utilized in dermatology for melanoma detection and skin barrier assessments, contributing to proactive skin health management globally.
- Headquarters Stockholm, Sweden
- Employees 32
- Founders Stig Ollmar
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website scibase.com/us
- Social LinkedIn X Facebook
- Legal Name Scibase Holding Ab
- Annual Revenue$4.39 M (USD)36.21as on Dec 31, 2025
- Net Profit-$9.45 M (USD)-32.76as on Dec 31, 2025
- EBITDA-$8.85 M (USD)-27.87as on Dec 31, 2025
- Total Equity Funding$22.3M (USD)
in 3 rounds
- InvestorsSEB
& 6 more
- Employee Count32
Products & Services of SciBase
SciBase offers a comprehensive portfolio of products and services, including Nevisense and Skin Barrier Assessment.
Nevisense is used for early skin cancer detection.
Skin barrier function is assessed using Nevisense platform.
Funding Insights of SciBase
SciBase has successfully raised a total of $22.3M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $22.3M
- Total Rounds 3
- First Round $4.3M
(Feb 2005)
- Investors Count 7
All 3 funding rounds of SciBase with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2021 | Post-IPO | – | – | ||
| Dec 2013 | $18M | Series B | – | – | |
| Feb 2005 | $4.3M | Series A | – | – |
7 investors in total: 7 institutional.
Investors in SciBase
SciBase has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include SEB, CapMan and Van Herk Groep.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life-Sciences & Offline focused VC firm funding companies in Netherlands | vanherkgroep.nl | Rotterdam, Netherlands | ||
Venture capital firm backed by SEB group | sebgroup.com/large-corporates-and-institutions/our-services/seb-venture-capital | Stockholm, Sweden | ||
A state-owned venture capital company focused on sustainable investments. | 2016 | fouriertransform.se | Stockholm, Sweden | |
Venture capital firm | omegafunds.com | Boston, United States | ||
Diversified investment management firm | 1989 | capman.com | Helsinki, Finland | |
SEB is recognized as a leading Nordic corporate bank. | 1856 | sebgroup.com | Stockholm, Sweden | |
| ostvast.com |
Investor details for SciBase
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SciBase
9 people are tracked at SciBase (6 in leadership, 3 in team); the tracked headcount is 32.
| Name | Role | Group |
|---|---|---|
Stig Ollmar | Founder | Leadership |
Emanuel von Kienlin | CEO | Leadership |
Linn Olsen | Chief Operating Officer | Leadership |
Jvalini Dwarkasing | Head Medical Affairs | Leadership |
Michael Colerus | CFO | Leadership |
Dr. Emanuel von Kienlin | Managing Director | Leadership |
Sophie Palmquist Klockhoff | Marketing Manager | Team |
Nima Askary Lord | Dir. Clinical & Product Management | Team |
Rasmus Larsson | Software Development Manager | Team |
Complete people profiles for SciBase
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of SciBase
SciBase is a publicly listed company on the OMXSTO with ticker symbol SCIB in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date02 Jun 2015
- Listed onNASDAQ OMX: SCIB
- Listed entitySciBase Holding AB
- Exchange sectorHealth technology
- ISINSE0029277631
- Share price15.90 SEK (+15.22% on the day) · 2026-10-14
- Market capitalisation194,025,060.00 SEK
- EPS (diluted, trailing year)-15.15 SEK
- Volume (last session)3,138
Financials of SciBase
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 40.5M SEK | -87.1M SEK | -81.5M SEK |
| 2024 | 29.7M SEK | -65.6M SEK | -63.7M SEK |
| 2023 | 23.2M SEK | -55.6M SEK | -50.5M SEK |
| 2022 | 17.9M SEK | -43.2M SEK | -42.8M SEK |
| 2021 | 11.7M SEK | -41.8M SEK | -39.4M SEK |
Detailed financial statements for SciBase
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of SciBase
4 dated milestones of SciBase across 23 years, from founding to its latest funding, stage changes and deals.
- Founded SciBase is founded.
- Funding First funding round of $4.3M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO,.
Web traffic of SciBase
The website of SciBase (scibase.com) receives about 3.4K visits a month.
- Monthly visits3.4K
▲ 3.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Scibase
Complete news archive for SciBase
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SciBase
SciBase was founded in 1998 and raised its 1st funding round 7 years after it was founded.
SciBase is headquartered in Stockholm, Sweden.
Emanuel von Kienlin is the CEO of SciBase, as recorded in our data.
SciBase is a funded company, having raised a total of $22.3M across 3 funding rounds to date. The company's 1st funding round was a Series A of $4.3M, raised on Feb 2005.
SciBase has 32 employees.
Annual revenue of SciBase is $4.39M as on Dec 31, 2025.
SciBase is focused on the development and commercialization of Nevisense, a point-of-care platform integrating AI and advanced EIS technology. The company operates in the healthcare sector, specifically targeting early detection and prevention of skin cancer and skin disorders. Solutions provided by SciBase empower healthcare professionals to improve diagnostic accuracy, facilitate disease monitoring, and enable early intervention. The platform is utilized in dermatology for melanoma detection and skin barrier assessments, contributing to proactive skin health management globally.
SciBase offers Nevisense and Skin Barrier Assessment.
Yes, SciBase is publicly traded on OMXSTO under the ticker symbol SCIB.
SciBase has 7 investors. Key investors include SEB, CapMan, Van Herk Groep, ÖstVäst Advisory AB, and SEB Venture Capital.
SciBase operates through Scibase Ab.